167 related articles for article (PubMed ID: 36609474)
1. A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer.
Chen Y; Ying Y; Wang M; Ma C; Jia M; Shi L; Wang S; Zheng X; Chen W; Shu XS
Cell Death Dis; 2023 Jan; 14(1):8. PubMed ID: 36609474
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer.
Wang H; Huang R; Guo W; Qin X; Yang Z; Yuan Z; Wei Y; Mo C; Zeng Z; Luo J; Cai J; Wang H
Clin Sci (Lond); 2020 Jul; 134(14):1973-1990. PubMed ID: 32677671
[TBL] [Abstract][Full Text] [Related]
3. E26 Transformation-Specific Transcription Factor ETS2 as an Oncogene Promotes the Progression of Hypopharyngeal Cancer.
Liu X; Zhang C; Zhang Z; Zhang Z; Ji W; Cao S; Cai X; Lei D; Pan X
Cancer Biother Radiopharm; 2017 Nov; 32(9):327-334. PubMed ID: 29111780
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
[TBL] [Abstract][Full Text] [Related]
5. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.
Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA
Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679
[TBL] [Abstract][Full Text] [Related]
6. EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.
De Weer A; Van der Meulen J; Rondou P; Taghon T; Konrad TA; De Preter K; Mestdagh P; Van Maerken T; Van Roy N; Jeison M; Yaniv I; Cauwelier B; Noens L; Poirel HA; Vandenberghe P; Lambert F; De Paepe A; Sánchez MG; Odero M; Verhasselt B; Philippé J; Vandesompele J; Wieser R; Dastugue N; Van Vlierberghe P; Poppe B; Speleman F
Br J Haematol; 2011 Aug; 154(3):337-48. PubMed ID: 21569010
[TBL] [Abstract][Full Text] [Related]
7. Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2.
Plotnik JP; Hollenhorst PC
Nucleic Acids Res; 2017 May; 45(8):4452-4462. PubMed ID: 28119415
[TBL] [Abstract][Full Text] [Related]
8. Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.
Xu D; Dwyer J; Li H; Duan W; Liu JP
J Biol Chem; 2008 Aug; 283(35):23567-80. PubMed ID: 18586674
[TBL] [Abstract][Full Text] [Related]
9. Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
Mole DJ; O'Neill C; Hamilton P; Olabi B; Robinson V; Williams L; Diamond T; El-Tanani M; Campbell FC
Br J Cancer; 2011 Mar; 104(6):1007-12. PubMed ID: 21343932
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.
Kabbout M; Dakhlallah D; Sharma S; Bronisz A; Srinivasan R; Piper M; Marsh CB; Ostrowski MC
PLoS One; 2014; 9(6):e100693. PubMed ID: 24968297
[TBL] [Abstract][Full Text] [Related]
11. USP39-Mediated Non-Proteolytic Control of ETS2 Suppresses Nuclear Localization and Activity.
Choi Y; Lee Y; Kim JS; Zhang P; Kim J
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892157
[TBL] [Abstract][Full Text] [Related]
12. ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.
Kabbout M; Garcia MM; Fujimoto J; Liu DD; Woods D; Chow CW; Mendoza G; Momin AA; James BP; Solis L; Behrens C; Lee JJ; Wistuba II; Kadara H
Clin Cancer Res; 2013 Jul; 19(13):3383-95. PubMed ID: 23659968
[TBL] [Abstract][Full Text] [Related]
13. Squelching of ETS2 transactivation by POU5F1 silences the human chorionic gonadotropin CGA subunit gene in human choriocarcinoma and embryonic stem cells.
Gupta R; Ezashi T; Roberts RM
Mol Endocrinol; 2012 May; 26(5):859-72. PubMed ID: 22446105
[TBL] [Abstract][Full Text] [Related]
14. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
[TBL] [Abstract][Full Text] [Related]
16. The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10.
Quinn SR; Mangan NE; Caffrey BE; Gantier MP; Williams BR; Hertzog PJ; McCoy CE; O'Neill LA
J Biol Chem; 2014 Feb; 289(7):4316-25. PubMed ID: 24362029
[TBL] [Abstract][Full Text] [Related]
17. Identification of nuclear localization and nuclear export signals in Ets2, and the transcriptional regulation of Ets2 and CTP:phosphocholine cytidylyltransferase alpha in tetradecanoyl-13-acetate or macrophage-colony stimulating factor stimulated RAW264 cells.
Okamura K; Yamashita S; Ando H; Horibata Y; Aoyama C; Takagishi K; Izumi T; Vance DE; Sugimoto H
Biochim Biophys Acta; 2009 Mar; 1791(3):173-82. PubMed ID: 19168148
[TBL] [Abstract][Full Text] [Related]
18. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
[TBL] [Abstract][Full Text] [Related]
19. Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer.
Yan L; Chen H; Tang L; Jiang P; Yan F
BMC Cancer; 2021 Feb; 21(1):187. PubMed ID: 33622275
[TBL] [Abstract][Full Text] [Related]
20. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner.
Basuyaux JP; Ferreira E; Stéhelin D; Butticè G
J Biol Chem; 1997 Oct; 272(42):26188-95. PubMed ID: 9334186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
